NYSE:CC - The Chemours Stock Price, Price Target & More

$51.92 -0.70 (-1.33 %)
(As of 04/20/2018 03:06 AM ET)
Previous Close$52.62
Today's Range$51.24 - $52.82
52-Week Range$34.84 - $58.08
Volume1.24 million shs
Average Volume1.83 million shs
Market Capitalization$9.54 billion
P/E Ratio13.59
Dividend Yield1.30%
Beta2.95

About The Chemours (NYSE:CC)

The Chemours logoThe Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Fluoroproducts, and Chemical Solutions. The Titanium Technologies segment manufactures and sells titanium dioxide under the Ti-Pure and BaiMax brands for various applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride window profiles, laminate papers used for furniture and building materials, and coated papers and paperboards used for packaging. The Fluoroproducts segment provides fluoroproducts, including refrigerants, and industrial fluoropolymer resins and derivatives under the Teflon, Viton, Krytox, and Nafion brand names. The Chemical Solutions segment offers industrial and specialty chemicals for gold production, oil and gas, water treatment, electronics, and automotive industries. It also provides sodium cyanide through its mining solutions business; and performance chemicals and intermediates, such as methylamines, glycolic acid, and Vazo free radical initiators. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Receive CC News and Ratings via Email

Sign-up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustryN/A
SectorBasic Materials
SymbolNYSE:CC
CUSIPN/A
Phone302-773-1000

Debt

Debt-to-Equity Ratio4.74%
Current Ratio2.12%
Quick Ratio1.55%

Price-To-Earnings

Trailing P/E Ratio13.59
Forward P/E Ratio9.67
P/E Growth0.63

Sales & Book Value

Annual Sales$6.18 billion
Price / Sales1.53
Cash Flow$5.4423 per share
Price / Cash9.54
Book Value$4.67 per share
Price / Book11.12

Profitability

EPS (Most Recent Fiscal Year)$3.82
Net Income$746 million
Net Margins12.06%
Return on Equity115.54%
Return on Assets10.83%

Miscellaneous

Employees7,000
Outstanding Shares182,520,000

How to Become a New Pot Stock Millionaire

The Chemours (NYSE:CC) Frequently Asked Questions

What is The Chemours' stock symbol?

The Chemours trades on the New York Stock Exchange (NYSE) under the ticker symbol "CC."

How often does The Chemours pay dividends? What is the dividend yield for The Chemours?

The Chemours declared a quarterly dividend on Friday, December 1st. Stockholders of record on Thursday, February 15th will be paid a dividend of $0.17 per share on Thursday, March 15th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.31%. The ex-dividend date of this dividend is Wednesday, February 14th. This is an increase from The Chemours's previous quarterly dividend of $0.03. View The Chemours' Dividend History.

How will The Chemours' stock buyback program work?

The Chemours announced that its board has authorized a share repurchase program on Monday, December 4th 2017, which authorizes the company to repurchase $500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's board believes its stock is undervalued.

How were The Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) issued its quarterly earnings data on Wednesday, February, 14th. The specialty chemicals company reported $1.19 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.95 by $0.24. The specialty chemicals company earned $1.58 billion during the quarter, compared to analyst estimates of $1.55 billion. The Chemours had a return on equity of 115.54% and a net margin of 12.06%. The firm's revenue for the quarter was up 19.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.08 EPS. View The Chemours' Earnings History.

When is The Chemours' next earnings date?

The Chemours is scheduled to release their next quarterly earnings announcement on Thursday, May, 3rd 2018. View Earnings Estimates for The Chemours.

What guidance has The Chemours issued on next quarter's earnings?

The Chemours issued an update on its FY18 earnings guidance on Wednesday, February, 14th. The company provided earnings per share guidance of $4.95-5.60 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.09.

What price target have analysts set for CC?

10 equities research analysts have issued twelve-month price objectives for The Chemours' shares. Their predictions range from $55.00 to $68.00. On average, they anticipate The Chemours' share price to reach $59.65 in the next twelve months. View Analyst Ratings for The Chemours.

Who are some of The Chemours' key competitors?

Who are The Chemours' key executives?

The Chemours' management team includes the folowing people:
  • Mr. Mark P. Vergnano, Pres, CEO & Director (Age 60)
  • Mr. Mark E. Newman, Sr. VP & CFO (Age 55)
  • Mr. David C. Shelton Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Mr. E. Bryan Snell, Pres of Titanium Technologies (Age 61)
  • Mr. Paul Kirsch, Pres of Fluoroproducts Bus. (Age 54)

Has The Chemours been receiving favorable news coverage?

News headlines about CC stock have been trending positive recently, Accern Sentiment reports. Accern ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. The Chemours earned a coverage optimism score of 0.36 on Accern's scale. They also gave news articles about the specialty chemicals company an impact score of 48.19 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

How do I buy shares of The Chemours?

Shares of CC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is The Chemours' stock price today?

One share of CC stock can currently be purchased for approximately $51.92.

How big of a company is The Chemours?

The Chemours has a market capitalization of $9.54 billion and generates $6.18 billion in revenue each year. The specialty chemicals company earns $746 million in net income (profit) each year or $3.82 on an earnings per share basis. The Chemours employs 7,000 workers across the globe.

How can I contact The Chemours?

The Chemours' mailing address is 1007 MARKET STREET, WILMINGTON DE, 19899. The specialty chemicals company can be reached via phone at 302-773-1000 or via email at [email protected]


MarketBeat Community Rating for The Chemours (CC)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  229 (Vote Underperform)
Total Votes:  408
MarketBeat's community ratings are surveys of what our community members think about The Chemours and other stocks. Vote "Outperform" if you believe CC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CC will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

The Chemours (NYSE:CC) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
10 Wall Street analysts have issued ratings and price targets for The Chemours in the last 12 months. Their average twelve-month price target is $59.65, suggesting that the stock has a possible upside of 14.89%. The high price target for CC is $68.00 and the low price target for CC is $55.00. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.702.672.752.86
Ratings Breakdown: 0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $59.65$57.9444$58.00$51.5714
Price Target Upside: 14.89% upside8.13% upside25.36% upside16.13% upside

The Chemours (NYSE:CC) Consensus Price Target History

Price Target History for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/10/2018CitigroupLower Price TargetBuy -> Buy$68.00 -> $66.00LowView Rating Details
3/27/2018BMO Capital MarketsInitiated CoverageOutperform$68.00MediumView Rating Details
1/30/2018Morgan StanleyInitiated CoverageEqual -> Equal Weight$57.50MediumView Rating Details
12/6/2017BarclaysReiterated RatingBuy$60.00LowView Rating Details
12/6/2017Goldman SachsDowngradeBuy -> Neutral$55.00MediumView Rating Details
12/4/2017Jefferies GroupBoost Price TargetBuy$66.00HighView Rating Details
11/3/2017UBSBoost Price TargetNeutral$50.00 -> $59.00N/AView Rating Details
8/10/2017ArgusReiterated RatingBuy$50.00 -> $55.00HighView Rating Details
8/4/2017JPMorgan ChaseBoost Price TargetOverweight$55.00LowView Rating Details
5/15/2017Susquehanna BancsharesBoost Price TargetPositive$45.00 -> $55.00LowView Rating Details
(Data available from 4/20/2016 forward)

Earnings

The Chemours (NYSE:CC) Earnings History and Estimates Chart

Earnings by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Earnings Estimates

2018 EPS Consensus Estimate: $5.51
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$1.26$1.26$1.26
Q2 20181$1.42$1.42$1.42
Q3 20181$1.36$1.36$1.36
Q4 20181$1.47$1.47$1.47

The Chemours (NYSE CC) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2018$1.12N/AView Earnings Details
2/14/2018Q4 2017$0.95$1.19$1.5535 billion$1.5750 billionViewListenView Earnings Details
11/2/2017Q3 2017$1.01$1.12$1.5881 billion$1.5840 billionViewN/AView Earnings Details
8/2/2017Q2 2017$0.85$0.87$1.4889 billion$1.5880 billionViewListenView Earnings Details
5/1/2017Q1 2017$0.5010$0.75$1.3238 billion$1.4370 billionViewListenView Earnings Details
2/15/2017Q416$0.29$0.08$1.24 billion$1.30 billionViewN/AView Earnings Details
11/6/2016Q3 2016$0.25$0.61$1.2950 billion$1.3980 billionViewN/AView Earnings Details
8/8/2016Q216$0.17$0.27$1.42 billion$1.3830 billionViewN/AView Earnings Details
5/2/2016Q116$0.02$0.06$1.27 billion$1.2970 billionViewN/AView Earnings Details
2/23/2016Q415$0.09$0.03$1.36 billion$1.40 billionViewListenView Earnings Details
11/5/2015Q315$0.26$0.40$1.52 billion$1.4860 billionViewN/AView Earnings Details
8/6/2015Q215$0.33$0.24$1.53 billion$1.50 billionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

The Chemours (NYSE:CC) Dividend Information

The Chemours pays an annual dividend of $0.68 per share, with a dividend yield of 1.31%. CC's most recent quarterly dividend payment was Thursday, March 15. The Chemours pays out 17.80% of its earnings out as a dividend.
Most Recent Dividend:3/15/2018
Annual Dividend:$0.68
Dividend Yield:1.31%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:17.80% (Trailing 12 Months of Earnings)
12.66% (Based on This Year's Estimates)
11.39% (Based on Next Year's Estimates)
Frequency:Quarterly Dividend
Dividend Payments by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE:CC) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/1/2017Quarterly$0.171.43%2/14/20182/15/20183/15/2018
11/7/2017quarterly$0.030.24%11/17/201711/20/201712/15/2017
8/2/2017quarterly$0.030.25%8/15/20178/17/20179/15/2017
4/27/2017quarterly$0.030.3%5/15/20175/17/20176/15/2017
2/14/2017quarterly$0.030.37%2/23/20172/27/20173/15/2017
11/2/2016quarterly$0.030.72%11/15/201611/17/201612/15/2016
8/3/2016quarterly$0.031.34%8/15/20168/17/20169/15/2016
4/27/2016quarterly$0.031.27%5/13/20165/17/20166/15/2016
2/23/2016quarterly$0.032.44%3/9/20163/11/20163/31/2016
9/1/2015quarterly$0.031.38%11/10/201511/13/201512/14/2015
7/24/2015special$0.557/30/20158/3/20159/11/2015
(Data available from 1/1/2013 forward)

Insider Trades

The Chemours (NYSE CC) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 1.75%
Institutional Ownership Percentage: 77.80%
Insider Trading History for The Chemours (NYSE:CC)
Institutional Ownership by Quarter for The Chemours (NYSE:CC)

The Chemours (NYSE CC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/17/2018Erich ParkerSVPSell5,000$52.00$260,000.00View SEC Filing  
3/9/2018Mark NewmanVPSell29,381$49.19$1,445,251.39View SEC Filing  
2/20/2018Paul KirschInsiderSell13,770$50.01$688,637.7063,093View SEC Filing  
12/13/2017Christian W. SiemerInsiderSell15,088$47.37$714,718.56View SEC Filing  
11/6/2017E Bryan SnellInsiderSell11,878$53.25$632,503.5063,063View SEC Filing  
10/13/2017David C SheltonSVPSell5,908$56.01$330,907.0847,356View SEC Filing  
10/10/2017David C SheltonSVPSell13,397$55.00$736,835.00View SEC Filing  
10/5/2017David C SheltonSVPSell19,000$53.68$1,019,920.00View SEC Filing  
9/5/2017E Bryan SnellInsiderSell13,000$49.35$641,550.00View SEC Filing  
8/31/2017David C. SheltonSVPSell13,337$48.48$646,577.76View SEC Filing  
8/11/2017Amy TrojanowskiVPSell2,500$46.03$115,075.00View SEC Filing  
8/11/2017E Bryan SnellInsiderSell10,000$46.24$462,400.00View SEC Filing  
6/5/2017Paul KirschInsiderSell19,036$41.42$788,471.12View SEC Filing  
5/16/2017Erich ParkerVPSell4,908$45.53$223,461.24View SEC Filing  
5/5/2017Mark NewmanVPSell22,781$39.83$907,367.23View SEC Filing  
5/3/2017Richard H. BrownDirectorBuy2,500$39.10$97,750.00View SEC Filing  
5/13/2016Mark NewmanCFOBuy2,800$9.71$27,188.00108,533View SEC Filing  
5/4/2016Bradley J BellDirectorBuy10,000$9.65$96,500.0021,747View SEC Filing  
2/26/2016Stephen D. NewlinDirectorBuy10,000$4.94$49,400.00View SEC Filing  
11/23/2015Thierry Fj VanlanckerInsiderBuy15,000$6.00$90,000.00190,022View SEC Filing  
9/14/2015E Bryan SnellInsiderBuy8,000$8.89$71,120.0022,051View SEC Filing  
9/11/2015Amy TrojanowskiVPBuy5,400$9.24$49,896.0011,982View SEC Filing  
9/10/2015Christian W SiemerInsiderBuy10,100$9.39$94,839.0031,843View SEC Filing  
9/9/2015Mark NewmanCFOBuy10,600$9.32$98,792.00114,109View SEC Filing  
9/8/2015Christian W SiemerInsiderBuy11,000$9.11$100,210.0021,743View SEC Filing  
9/4/2015David C SheltonSVPBuy5,000$9.00$45,000.0013,183View SEC Filing  
9/4/2015Mark P VergnanoCEOBuy72,600$9.25$671,550.00321,337View SEC Filing  
9/4/2015Stephen D. NewlinDirectorBuy7,000$9.18$64,260.0016,680View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

The Chemours (NYSE CC) News Headlines

Source:
DateHeadline
The Chemours Company (CC) SVP Sells $260,000.00 in StockThe Chemours Company (CC) SVP Sells $260,000.00 in Stock
www.americanbankingnews.com - April 19 at 10:10 PM
Chemours (CC) Stock Rating Upgraded by BidaskClubChemours (CC) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - April 18 at 6:54 PM
Fast and loose: Plaintiffs respond to motion to dismiss GenX case'Fast and loose': Plaintiffs respond to motion to dismiss GenX case
www.bizjournals.com - April 17 at 9:53 AM
'Fast and loose': Plaintiffs respond to motion to dismiss GenX case'Fast and loose': Plaintiffs respond to motion to dismiss GenX case
finance.yahoo.com - April 16 at 4:22 PM
Jefferies Group Raises Chemours (CC) Price Target to $60.00Jefferies Group Raises Chemours (CC) Price Target to $60.00
www.americanbankingnews.com - April 13 at 7:49 PM
Chemours (CC) Rating Increased to Neutral at UBSChemours (CC) Rating Increased to Neutral at UBS
www.americanbankingnews.com - April 13 at 12:58 AM
June 1st Options Now Available For Chemours (CC)June 1st Options Now Available For Chemours (CC)
www.nasdaq.com - April 12 at 4:19 PM
Why Chemours Company (CC) Could Beat Earnings Estimates Again April 11, 2018Why Chemours Company (CC) Could Beat Earnings Estimates Again April 11, 2018
www.zacks.com - April 12 at 10:38 AM
Why Chemours Company (CC) Could Beat Earnings Estimates AgainWhy Chemours Company (CC) Could Beat Earnings Estimates Again
finance.yahoo.com - April 11 at 10:28 AM
Citigroup Lowers Chemours (CC) Price Target to $66.00Citigroup Lowers Chemours (CC) Price Target to $66.00
www.americanbankingnews.com - April 10 at 11:29 AM
NC puts Chemours on notice over GenX air emissionsNC puts Chemours on notice over GenX air emissions
www.bizjournals.com - April 9 at 4:16 PM
Why Chemours Company (CC) Could Be an Impressive Growth Stock April 09, 2018Why Chemours Company (CC) Could Be an Impressive Growth Stock April 09, 2018
www.zacks.com - April 9 at 4:16 PM
Analyzing Innospec (IOSP) and Chemours (CC)Analyzing Innospec (IOSP) and Chemours (CC)
www.americanbankingnews.com - April 6 at 9:26 PM
Chemours Co (CC) Receives Consensus Rating of "Buy" from BrokeragesChemours Co (CC) Receives Consensus Rating of "Buy" from Brokerages
www.americanbankingnews.com - April 5 at 1:44 PM
Top Ranked Value Stocks to Buy for April 5thTop Ranked Value Stocks to Buy for April 5th
finance.yahoo.com - April 5 at 8:49 AM
Is Chemours (CC) a Great Stock for Value Investors?Is Chemours (CC) a Great Stock for Value Investors?
www.nasdaq.com - April 4 at 5:14 PM
Chemours (CC) Upgraded to B- by TheStreetChemours (CC) Upgraded to B- by TheStreet
www.americanbankingnews.com - April 4 at 12:49 PM
Chemours (CC) Downgraded to Hold at ValuEngineChemours (CC) Downgraded to Hold at ValuEngine
www.americanbankingnews.com - April 3 at 6:26 PM
Zacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied MaterialsZacks.com highlights: Chemours, Activision Blizzard, Jones Lang LaSalle, Avery Dennison and Applied Materials
finance.yahoo.com - April 3 at 10:06 AM
Chemours (CC) Looks Good: Stock Adds 5.4% in Session April 02, 2018Chemours (CC) Looks Good: Stock Adds 5.4% in Session April 02, 2018
www.zacks.com - April 2 at 10:26 AM
Chemours (CC) Looks Good: Stock Adds 5.4% in SessionChemours (CC) Looks Good: Stock Adds 5.4% in Session
www.nasdaq.com - April 2 at 10:26 AM
Barclays Remains Bullish on Chemours (CC)Barclays Remains Bullish on Chemours (CC)
www.streetinsider.com - March 29 at 10:13 AM
Chemours Co to Post Q4 2018 Earnings of $1.47 Per Share, Jefferies Group Forecasts (CC)Chemours Co to Post Q4 2018 Earnings of $1.47 Per Share, Jefferies Group Forecasts (CC)
www.americanbankingnews.com - March 29 at 8:13 AM
Research Analysts Set Expectations for Chemours Cos Q1 2018 Earnings (CC)Research Analysts Set Expectations for Chemours Co's Q1 2018 Earnings (CC)
www.americanbankingnews.com - March 28 at 6:34 AM
Chemours (CC) Now Covered by BMO Capital MarketsChemours (CC) Now Covered by BMO Capital Markets
www.americanbankingnews.com - March 27 at 5:44 PM
Heres Why You Should Add Chemours (CC) to Your PortfolioHere's Why You Should Add Chemours (CC) to Your Portfolio
www.zacks.com - March 27 at 4:19 PM
Here's Why You Should Add Chemours (CC) to Your PortfolioHere's Why You Should Add Chemours (CC) to Your Portfolio
finance.yahoo.com - March 27 at 4:19 PM
Teflon maker Chemours sees more profit in 2018Teflon maker Chemours sees more profit in 2018
www.marketwatch.com - March 27 at 9:56 AM
Chemours sees full-year earnings at high end of prior guidanceChemours sees full-year earnings at high end of prior guidance
seekingalpha.com - March 27 at 9:56 AM
Chemours (CC) Coverage Initiated at Morgan StanleyChemours (CC) Coverage Initiated at Morgan Stanley
www.americanbankingnews.com - March 26 at 3:13 PM
Financial Contrast: Platform Specialty Products (PAH) vs. Chemours (CC)Financial Contrast: Platform Specialty Products (PAH) vs. Chemours (CC)
www.americanbankingnews.com - March 21 at 5:18 PM
Chemours Company, (The) -- Moodys assigns Baa3 to Chemours New Senior Secured Credit facilitiesChemours Company, (The) -- Moody's assigns Baa3 to Chemours' New Senior Secured Credit facilities
finance.yahoo.com - March 20 at 9:43 AM
Access Group, Inc. Series 2007-1 -- Moodys assigns Baa3 to Chemours New Senior Secured Credit facilitiesAccess Group, Inc. Series 2007-1 -- Moody's assigns Baa3 to Chemours' New Senior Secured Credit facilities
finance.yahoo.com - March 19 at 4:19 PM
Why Analysts Are Positive on W.R. GraceWhy Analysts Are Positive on W.R. Grace
finance.yahoo.com - March 16 at 4:23 PM
Top Ranked Value Stocks to Buy for March 16thTop Ranked Value Stocks to Buy for March 16th
finance.yahoo.com - March 16 at 10:47 AM
PPG Industries to Hike Price of Automotive OEM CoatingsPPG Industries to Hike Price of Automotive OEM Coatings
finance.yahoo.com - March 15 at 4:16 PM
Nucor (NUE) Set to Construct Rebar Micro Mill in FloridaNucor (NUE) Set to Construct Rebar Micro Mill in Florida
finance.yahoo.com - March 14 at 12:36 PM
Reviewing Albemarle (ALB) and Chemours (CC)Reviewing Albemarle (ALB) and Chemours (CC)
www.americanbankingnews.com - March 11 at 4:02 PM
Chemours Co (CC) Receives Average Recommendation of "Buy" from AnalystsChemours Co (CC) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - March 11 at 12:47 PM
Insider Selling: Chemours Co (CC) VP Sells 29,381 Shares of StockInsider Selling: Chemours Co (CC) VP Sells 29,381 Shares of Stock
www.americanbankingnews.com - March 10 at 4:21 AM
Head to Head Survey: Taminco (TAM) & Chemours (CC)Head to Head Survey: Taminco (TAM) & Chemours (CC)
www.americanbankingnews.com - March 8 at 5:24 AM
Thinking about buying or selling stock or options in Boeing, Chemours Co, Myomo Inc, Netflix and Visa?Thinking about buying or selling stock or options in Boeing, Chemours Co, Myomo Inc, Netflix and Visa?
www.prnewswire.com - March 5 at 9:52 AM
Maverick Capital Ltd. Purchases 42,650 Shares of Chemours Co (CC)Maverick Capital Ltd. Purchases 42,650 Shares of Chemours Co (CC)
www.americanbankingnews.com - March 4 at 1:40 PM
Chemours Co (CC) Position Raised by UBS Asset Management Americas Inc.Chemours Co (CC) Position Raised by UBS Asset Management Americas Inc.
www.americanbankingnews.com - March 3 at 9:08 AM
What Does 3Ms $850 Million Legal Settlement Mean for Chemours ... - Motley FoolWhat Does 3M's $850 Million Legal Settlement Mean for Chemours ... - Motley Fool
www.fool.com - March 2 at 4:13 PM
Martingale Asset Management L P Trims Stake in Chemours Co (CC)Martingale Asset Management L P Trims Stake in Chemours Co (CC)
www.americanbankingnews.com - March 1 at 9:34 AM
Allianz Asset Management GmbH Decreases Position in Chemours Co (CC)Allianz Asset Management GmbH Decreases Position in Chemours Co (CC)
www.americanbankingnews.com - March 1 at 4:10 AM
Chemours Co (CC) Shares Bought by Horizon Investment Services LLCChemours Co (CC) Shares Bought by Horizon Investment Services LLC
www.americanbankingnews.com - February 28 at 4:50 PM
What Does 3M's $850 Million Legal Settlement Mean for Chemours Company?What Does 3M's $850 Million Legal Settlement Mean for Chemours Company?
finance.yahoo.com - February 28 at 4:19 PM
Chemours Company, (The) -- Moodys says risk to Chemours and DuPont steps up with new PFC litigationChemours Company, (The) -- Moody's says risk to Chemours and DuPont steps up with new PFC litigation
finance.yahoo.com - February 27 at 4:20 PM

SEC Filings

The Chemours (NYSE:CC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

The Chemours (NYSE:CC) Income Statement, Balance Sheet and Cash Flow Statement

Chart

The Chemours (NYSE CC) Stock Chart for Friday, April, 20, 2018

Loading chart…

This page was last updated on 4/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.